Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04543656
Other study ID # 1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2020
Est. completion date June 2022

Study information

Verified date September 2021
Source University of California, San Diego
Contact Sujit Dey, PhD
Phone 8587617518
Email dey@eng.ucsd.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this RCT, up to 100 adults classified as pre-hypertensive will be randomized to either an artificial intelligence (AI) based lifestyle intervention group or an active control group with a 1 to 1 ratio. Both groups will receive an identical activity tracker (Samsung Galaxy Watch) and BP monitor (Omron Evolv). The AI intervention group will receive automated and personalized lifestyle recommendations based on their lifestyle (e.g. sleep, exercise and diet) and blood pressure (BP) data, involving an automated analytics engine using statistics and machine learning. The active control group will not receive these lifestyle recommendations. The investigators aim to assess objectively the effectiveness of the AI-based personalized lifestyle recommendations on the patients BP.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date June 2022
Est. primary completion date June 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - age =18 years - SBP between 130 mmHg to 139 mmHg or/and DBP between 80 to 89 mmHg in a research office - speaking and reading English - having an iPhone 8 or newer or an Android x or newer Exclusion Criteria: - currently taking antihypertensive medication - self-reported diagnosis of coronary heart disease, medical condition or other physical problem necessitating special attention in an exercise program (e.g., cancer, eating disorder, uncontrolled diabetes) - current participation in a lifestyle modification program or research study - self-report of being currently pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
AI-Based Lifestyle Recommendations
The intervention provides participants with automated and personalized lifestyle recommendations involving a sophisticated analytics engine using advanced statistics and machine learning.
Other:
No Lifestyle Recommendations
The control group receives an identical activity tracker and BP monitor in order to objectively assess the effectiveness of the experimental group intervention.

Locations

Country Name City State
United States University of California, San Diego La Jolla California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Diego

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Average change in systolic blood pressure (SBP) in experimental vs. control group Average SBP during the first and last week of a patient's enrollment will be used to calculate SBP change for each patient. Initial 2 week data collection, weekly lifestyle recommendations, 6 months total
Primary Average change in diastolic blood pressure (DBP) in experimental vs. control group Average DBP during the first and last week of a patient's enrollment will be used to calculate DBP change for each patient. Initial 2 week data collection, weekly lifestyle recommendations, 6 months total
Secondary Number of patients in experimental group that followed lifestyle recommendations This secondary outcome measure is interested in assessing patient engagement within the experimental group. Data from the activity tracker (steps, sleep quality, active minutes, etc.) will be used to assess whether a patient followed the lifestyle recommendations. Initial 2 week data collection, weekly lifestyle recommendations, 6 months total
See also
  Status Clinical Trial Phase
Completed NCT03313284 - Respiratory Muscle Training and Intermittent Hypoxia: Additive Health Effects? N/A
Completed NCT01741779 - Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function N/A
Withdrawn NCT01074918 - Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients Phase 1/Phase 2
Completed NCT00288158 - Primary Prevention of Hypertension in Obese Adolescents Phase 2
Completed NCT01190319 - Study: Effects of Strawberries on Blood Pressure N/A
Completed NCT01008176 - Restoring Sleep Homeostasis to Lower Blood Pressure N/A
Unknown status NCT02197910 - Different Dosages of Bioactive Wheat Peptides and Blood Pressure Level and CVD Risk Biomarkers in Healthy Subjects N/A
Completed NCT03168789 - Tension Tamer Randomized Control Trial N/A
Completed NCT00553969 - Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease Phase 1/Phase 2
Completed NCT00170937 - A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome Phase 4
Completed NCT01741766 - The Effects of Stretching Training on Arterial Function and Autonomic Control N/A
Completed NCT02143817 - Whole Body Vibration Combined With L-citrulline Supplementation on Cardiovascular Function and Body Composition N/A
Terminated NCT00388388 - Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects Phase 2
Completed NCT02148458 - Short Term Intermittent Fasting and Mediterranean Diet N/A
Terminated NCT01349114 - Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects Phase 4
Completed NCT02038179 - Center of Research Translation (CORT) Project 2 Phase 2/Phase 3
Completed NCT00970931 - Hypertension Prevention in Pre-Hypertensive Individuals Phase 3
Completed NCT01202175 - Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension Phase 4
Not yet recruiting NCT01364675 - Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects N/A
Completed NCT01841840 - The Acute Effects of Passive Vibration on Cardiovascular Function in Individuals With Stroke N/A